Author: WTN News

Until recently, the 2007 stock market performance was nothing to write home about, with one notable exception, according to Yer Biotech Blues columnist Michael Rosen. Midwestern biotech stocks did so well that 18 stocks (72 percent) out of a basket of the top 25 stocks...

Is there a method to the methodology madness? Columnist and information technology strategist Patrick Gray says even the best methodology can't save a project beset with poor leadership and poor project management. Methodologies are important to an extent, he writes, but they pale in comparison...

TurboTax Online is a model for start ups looking to grow into a real business by delivering strong customer value, according to DEMO Letter columnist Chris Shipley, who was saved by TurboTax after procrastinating on her 2007 tax filing. She says new web entrepreneurs would...

Still trying to regain its footing after a potentially devastating financial scandal, Merge Healthcare hasn't given up trying to maintain and grab additional market share. The Milwaukee-area medical imaging software company is the latest to unveil a product enhancement that fuses imaging and informatics. ...

Emory Healthcare in Atlanta will install a radio frequency identification product from GE Healthcare to track medical equipment and improve its inventory management. The solution, which is called IntelliMotion, enables health facilities to conduct real-time equipment tracking. ...

Hewlett-Packard's Kristin Pugh visited Madison last week to address the subject of innovation, and advised smaller businesses to partner with a core group of clients to drive the innovative process. Hewlett-Packard, which has a 600-employee research and development lab, has acquired several smaller companies that...

In terms of prestige, Wisconsin should not be too alarmed by a recent patent office ruling that upheld the challenge to stem cell patents held by the Wisconsin Alumni Research Foundation. In this guest column, John M. Simpson of the Foundation for Taxpayer and Consumer...

Lucigen Corp. of Middleton has received a Phase II SBIR grant to complete development and commercialization of a new DNA polymerases, or enzymes, that could boost ethanol production. The follow-on grant is the second Lucigen has received as the result of bioprospecting for enzymes in...

For those who believe Wisconsin Alumni Research Foundation is in big trouble before the United States Patent and Trademark Office, remember that examiners of WARF's claims on stem cell patents have heard only from opponents, writes Inside Wisconsin columnist Tom Still. When the smoke clears...